Vericel Corp (VCEL)
56.71
-0.55
(-0.96%)
USD |
NASDAQ |
Nov 21, 16:00
57.80
+1.09
(+1.92%)
Pre-Market: 08:42
Vericel Total Assets (Quarterly): 390.40M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 390.40M |
June 30, 2024 | 376.84M |
March 31, 2024 | 356.66M |
December 31, 2023 | 353.66M |
September 30, 2023 | 318.12M |
June 30, 2023 | 310.71M |
March 31, 2023 | 265.10M |
December 31, 2022 | 273.00M |
September 30, 2022 | 248.02M |
June 30, 2022 | 244.82M |
March 31, 2022 | 240.29M |
December 31, 2021 | 243.70M |
September 30, 2021 | 224.14M |
June 30, 2021 | 221.94M |
March 31, 2021 | 211.46M |
December 31, 2020 | 205.61M |
September 30, 2020 | 157.50M |
June 30, 2020 | 146.69M |
March 31, 2020 | 150.26M |
December 31, 2019 | 153.24M |
September 30, 2019 | 137.53M |
June 30, 2019 | 125.83M |
March 31, 2019 | 141.23M |
December 31, 2018 | 118.69M |
September 30, 2018 | 124.46M |
Date | Value |
---|---|
June 30, 2018 | 122.19M |
March 31, 2018 | 52.41M |
December 31, 2017 | 54.58M |
September 30, 2017 | 40.28M |
June 30, 2017 | 36.53M |
March 31, 2017 | 40.59M |
December 31, 2016 | 48.60M |
September 30, 2016 | 28.02M |
June 30, 2016 | 29.43M |
March 31, 2016 | 33.06M |
December 31, 2015 | 34.31M |
September 30, 2015 | 35.82M |
June 30, 2015 | 41.22M |
March 31, 2015 | 44.49M |
December 31, 2014 | 47.58M |
September 30, 2014 | 50.38M |
June 30, 2014 | 19.84M |
March 31, 2014 | 9.878M |
December 31, 2013 | 9.215M |
September 30, 2013 | 12.20M |
June 30, 2013 | 5.683M |
March 31, 2013 | 10.58M |
December 31, 2012 | 15.18M |
September 30, 2012 | 22.71M |
June 30, 2012 | 30.44M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
146.69M
Minimum
Jun 2020
390.40M
Maximum
Sep 2024
254.61M
Average
244.26M
Median
Total Assets (Quarterly) Benchmarks
Catalyst Pharmaceuticals Inc | 772.01M |
Exelixis Inc | 2.960B |
Halozyme Therapeutics Inc | 2.118B |
ADMA Biologics Inc | 390.62M |
Natera Inc | 1.591B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 132.93M |
Shareholders Equity (Quarterly) | 257.47M |
Current Ratio | 4.608 |